Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The global prevalence of erectile dysfunction: a review.BJU Int. 2019; 124
- A scoping review of the economic burden of non-cancerous genitourinary conditions.Urology. 2021; (S0090–4295(21)00981-X)
- A review of economic evaluations of erectile dysfunction therapies.Sex Med Rev. 2020; 8: 497-503
- European Association of Urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction.Eur Urol. 2021; 80: 333-357
- Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs.Nat Rev Cardiol. 2022; 19: 59-74
- Physiology of erection and pathophysiology of erectile dysfunction.Urol Clin North Am. 2021; 48: 513-525
- Neurogenic erectile dysfunction. Where do we stand?.Med (Basel, Switzerland. 2021; 8: 3
- Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis.World J Urol. 2021; 39: 953-962
- Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.Eur. Urol. 2013; 63: 902-912
- Erectile dysfunction: a global review of intracavernosal injectables.World J Urol. 2019; 37: 1007-1014
- A systematic review of human trials using stem cell therapy for erectile dysfunction.Sex Med Rev. 2020; 8: 122-130
- Efficacy of low-intensity shock wave therapy for erectile dysfunction: a systematic review and meta-analysis.Actas Urol. Esp. 2017; 41: 479-490
- Risk factors associated with penile prosthesis infection: systematic review and meta-analysis.Int J Impot Res. 2020; 32: 587-597
J. R. Barr et al., “Botulinum Neurotoxin Detection and Differentiation by Mass Spectrometry - Volume 11, Number 10—October 2005 - Emerg Infect Dis.”
- Application of Botulinum Neurotoxin in Male Sexual Dysfunction: Where Are We Now?.Sex Med Rev. 2021; 9
Fda and Cder, “NDA/BLA Multi-Disciplinary Review and Evaluation: BOTOX”
- Safety of botulinum toxin type A: a systematic review and meta-analysis.Curr Med Res Opin. 2004; 20
- Botox for erectile dysfunction.J Sex Med. 2017; 14
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ. 2021; 372 (n): 71
- Assessing Risk of Bias in Included Studies.Cochrane Handb Syst Rev Interv Cochrane B Ser. Sep. 2008; : 187-241
- The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience.Int J Impot Res. May 2005; 17 (2005 174): 307-319
- Predictive correlation between the International Index of Erectile Function (IIEF) and Sexual Health Inventory for Men (SHIM): implications for calculating a derived SHIM for clinical use.J. Sex. Med. 2007; 4: 1336-1344
- 142 intracavernosal injection of botulinum toxin to improve erectile function in older rats.J Sex Med. Jan. 2017; 14: S40-S41
- 024 The effect of botulinum toxin on penile vascular parameters and clinical outcome in patients with severe ed: a pilot study.J Sex Med. Jan. 2017; 14: S11
- Botulinum neurotoxin and its potential role in the treatment of erectile dysfunction.Sex Med Rev. Jan. 2018; 6: 135-142
- Safety and efficacy of intracavernosal injections of AbobotulinumtoxinA (Dysport ®) as add on therapy to phosphosdiesterase type 5 inhibitors or prostaglandin E1 for erectile dysfunction-case studies.Toxins (Basel). May 2019; 11
- Comparative study between intracavernosal injection of botulinum toxin type A [50 and 100 unit], efficacy and durability in the treatment of vascular erectile dysfunction.Benha J. Appl. Sci. 2019; : 31-35
- Intra-cavernous injection of BOTOX® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial.Andrology. 2021; 9: 1166-1175
“Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction - Full Text View - ClinicalTrials.gov.” [Online]. Available: https://clinicaltrials.gov/ct2/show/NCT02584686. [Accessed: 05-Feb-2022].
“Botulinum Toxin for Erectile Dysfunction - Full Text View - ClinicalTrials.gov.” [Online]. Available: https://clinicaltrials.gov/ct2/show/NCT03102762. [Accessed: 05-Feb-2022].
“Intracavernous Injection of Botox 100 U for Treatment of PDE5Is Inconvenient Patients With ED - Full Text View - ClinicalTrials.gov.” [Online]. Available: https://clinicaltrials.gov/ct2/show/NCT04172558. [Accessed: 17-Jul-2022].
- Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agents–initial experience.Radiology. Dec. 2005; 237: 986-991
- Evaluation of the sensitivity of different doses of vasoactive drugs in diagnosing erectile dysfunction in impotent patients: a prospective case-control study,” Cent.Eur J Urol. 2021; 74: 109
- What is the current role of intracavernosal injection in management of erectile dysfunction?.Int J Impot Res. May 2016; 28: 88-95
- Intracavernosal injection for the diagnosis, evaluation, and treatment of erectile dysfunction: a review.Sex Med Rev. Mar. 2015; 3: 11-23
- Meta-analyses: what is heterogeneity?.BMJ. Mar. 2015; 350